12 Jun 2023
On 25 May 2023 the chancellor, Jeremy Hunt, announced a package of investment for the UK’s life sciences. As part of this, Lord O’Shaughnessy has published his Independent Review of commercial clinical trials in the UK. The review makes 27 recommendations focused on how the life sciences sector can develop UK health, growth and investment opportunities. We welcome this review and its recommendations; we also welcome the emphasis on the importance of clinical...